Kartik Bhatia | Medicine and Dentistry | Research Excellence Award

Assoc. Prof. Dr. Kartik Bhatia | Medicine and Dentistry | Research Excellence Award 

Clinical Associate Professor | University of Sydney | Australia

Associate Professor Dr. Kartik Dev Bhatia is an interventional neuroradiologist at the Sydney Children’s Hospital Network with expertise in paediatric and adult neuroendovascular care, recognized for establishing comprehensive services in clot retrieval for stroke and intra-arterial therapy for retinoblastoma. He holds a PhD and advanced clinical qualifications including subspecialty recognition in interventional neuroradiology, fellowship of the Royal Australian and New Zealand College of Radiologists, and dual medical and surgical degrees, underpinning a strong academic and clinical foundation. His professional experience spans leadership of multidisciplinary cerebrovascular programs, major fellowships across leading Australian and international centres, and service as a staff specialist and consultant interventional neuroradiologist across multiple tertiary hospitals. Dr. Bhatia’s research focuses on paediatric neurointervention, stroke, vascular malformations, and innovative endovascular therapies, with influential publications in high-impact journals and contributions to key international registries. He has authored multiple book chapters and serves as a reviewer for prominent journals in neuroradiology, neurology, and stroke medicine, reflecting his standing in the academic community. His work has advanced understanding of paediatric cerebrovascular disease, liquid biopsy applications in vascular malformations, and endovascular treatment paradigms. A recipient of distinctions including a Research Excellence Award, he also contributes through editorial activities, scholarly mentorship, and active membership in multidisciplinary and professional bodies. Dr. Bhatia’s blend of clinical innovation, academic leadership, and sustained research impact positions him as an outstanding candidate for recognition.

Citation Metrics (Google Scholar)

1500
1000
500
0

1409
Citations

22
h-index

30
i10-index


View Google Scholar Profile

Top Publications

Dr. Elif Coşkun Sungur | Medicine and Dentistry | Best Researcher Award

Dr. Elif Coşkun Sungur | Medicine and Dentistry | Best Researcher Award

Dr at Ankara Bilkent City Hospital Turkey

Dr. Elif Coşkun Sungur is an accomplished cardiovascular surgeon with extensive experience in clinical practice, academic research, and medical education. A graduate of Ondokuz Mayıs University Faculty of Medicine, she completed her specialization at Gazi University in Cardiovascular Surgery. Her professional career includes key roles in both public and private hospitals across Türkiye, currently serving at Ankara Bilkent City Hospital. Dr. Sungur has contributed significantly to national and international cardiovascular research, authoring over 30 peer-reviewed articles and case reports, and presenting numerous posters and oral papers at scientific congresses. She has actively participated in and organized multiple national and international cardiovascular meetings, demonstrating leadership and dedication to scientific advancement. Her research interests span deep vein thrombosis, endovascular procedures, and open-heart surgery. With additional certifications in radiology safety and experimental animal use, and intermediate proficiency in English, Dr. Sungur is recognized as a diligent researcher and clinician committed to innovation and multidisciplinary collaboration.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Elif Coşkun Sungur began her medical journey at Ondokuz Mayıs University Faculty of Medicine, where she earned her medical degree and developed a foundational understanding of clinical medicine. She then pursued specialized training in Cardiovascular Surgery at Gazi University, one of Türkiye’s leading institutions in medical education and research. During her specialization, she gained hands-on experience in complex surgical procedures and developed an academic interest in cardiovascular science. Her education also included certification in the use of laboratory animals in experimental research and a radiation safety course for medical staff, reflecting a commitment to maintaining high standards in both clinical and research environments. These qualifications allowed her to actively participate in experimental studies and radiological practices within her field. Her comprehensive education combined academic excellence, technical skill acquisition, and adherence to ethical and safety standards, laying the groundwork for a versatile and impactful career in cardiovascular surgery and medical research.

Professional Experience

Dr. Elif Coşkun Sungur has built a strong professional profile through her service in various prestigious healthcare institutions in Türkiye. She has worked in both public and private hospitals, gaining broad clinical experience with a focus on cardiovascular surgery. Currently, she serves at Ankara Bilkent City Hospital, one of the largest and most advanced medical centers in the country. Throughout her career, Dr. Sungur has been involved in the diagnosis, surgical treatment, and postoperative care of patients with complex cardiovascular conditions. Her role often includes collaboration with multidisciplinary teams, emphasizing patient-centered and evidence-based approaches. In addition to her clinical duties, she has played an active role in hospital-based educational programs, mentoring junior doctors and contributing to continuing medical education. Her diverse experience in multiple healthcare environments has enriched her surgical expertise, administrative understanding, and ability to adapt to evolving technologies and procedures in cardiovascular medicine.

Research Interest

Dr. Sungur’s research interests are centered around innovative and practical aspects of cardiovascular medicine and surgery. She has a strong focus on topics such as deep vein thrombosis (DVT), endovascular treatment techniques, and complex open-heart surgeries. Her investigations aim to bridge the gap between surgical interventions and long-term patient outcomes, with a particular emphasis on minimizing complications and improving quality of life. Dr. Sungur is also interested in the application of experimental models to better understand vascular diseases, having obtained certification in the use of laboratory animals for scientific studies. Her participation in multicenter trials and clinical case series reflects a commitment to generating high-quality, applicable medical evidence. Through her contributions to peer-reviewed journals and medical congresses, she continues to explore advancements in minimally invasive surgical techniques and hybrid approaches in cardiovascular treatment. Her research is marked by a practical orientation, interdisciplinary collaboration, and a desire to improve both procedural efficiency and patient care.

Award and Honor

Throughout her career, Dr. Elif Coşkun Sungur has received recognition for her contributions to cardiovascular surgery and medical research. She has authored over 30 peer-reviewed publications, including case reports, research articles, and review papers, many of which have been presented at prominent national and international conferences. Her work has earned her accolades for both oral and poster presentations at scientific congresses. These recognitions underscore her ability to translate clinical experience into valuable scientific contributions. Additionally, she has served on organizing committees for several high-profile cardiovascular symposiums and workshops, reflecting her leadership and dedication to advancing the field. Her academic achievements have been acknowledged by colleagues and professional societies alike, and her active engagement in professional development initiatives showcases her continuous pursuit of excellence. These honors affirm her status as a respected voice in cardiovascular surgery and research, appreciated for her thorough, innovative, and patient-focused work.

Conclusion

Dr. Elif Coşkun Sungur stands out as a multifaceted cardiovascular surgeon whose career blends rigorous education, extensive clinical experience, and impactful research. With a strong academic foundation from Ondokuz Mayıs and Gazi University, she has developed a nuanced understanding of cardiovascular disease and its treatment. Her work at major hospitals, including Ankara Bilkent City Hospital, highlights her practical expertise and commitment to patient care. In the research domain, she has contributed significantly to the scientific community, focusing on DVT, endovascular procedures, and heart surgeries, with more than 30 scientific publications to her name. Her dedication is further reflected in her recognition at medical conferences and involvement in scientific committees. Dr. Sungur exemplifies professionalism, innovation, and academic rigor, making her a valuable asset to both clinical and research settings. Her career continues to evolve as she remains committed to improving cardiovascular outcomes through science, education, and compassionate patient care.

Publications Top Notes

  • Title: Incidentally detected sternal foramen during an urgent surgical revascularization: A case report
    Authors: EC Sungur, U Tütün, A Tekin
    Year: 2020
    Citations: 7

  • Title: Aberrant right subclavian artery (arteria lusoria) aneurysm with a Kommerell’s diverticulum
    Authors: E Coşkun, L Altınay, A Tekin, U Tütün
    Year: 2019
    Citations: 7

  • Title: Off-pump coronary artery bypass grafting in moyamoya disease: a case report
    Authors: E Coşkun, L Altinay, U Tutun, A Tekin
    Year: 2018
    Citations: 4

  • Title: Bronchopericardial fistula, an unusual complication of oxytetracycline sclerosis therapy
    Authors: A Grbolar, L Qaradaghi, Y Imren, I Tasoglu, E Coskun, T Avcı
    Year: 2008
    Citations: 4

  • Title: Entrapment of broken guidewire in the coronary artery: a rare percutaneous coronary intervention complication requiring urgent revascularization
    Authors: E Coskun, L Altınay, A Tekin, U Tutun
    Year: 2019
    Citations: 3

  • Title: Epicardial anthracosis in a patient undergoing coronary artery bypass graft surgery
    Authors: L Altınay, E Coşkun, A Tekin, U Tütün
    Year: 2018
    Citations: 2

  • Title: The Influence of Comorbid Conditions on Graft Stenosis in Patients with Coronary Artery Bypass Graft Operation
    Authors: T Karabag, B Kalayci, B Sahin, E Coskun, MU Somuncu, MO Cakir
    Year: 2018
    Citations: 2

  • Title: Koroner arter bypass greft cerrahisi sonrası oluşan psödotrombositopeni ve literatürün gözden geçirilmesi
    Authors: M Büyükateş, E Coşkun
    Year: 2014
    Citations: 2

  • Title: Extrapelvic intravenous uterine leiomyomatosis mimicking cardiac myxoma and deep vein thrombosis
    Authors: EC Sungur, İ Selçuk, HM Özbek, O Aytekin, NÖ Köklü, N Turhan, S Talay, …
    Year: 2022
    Citations: 1

  • Title: The relation between neurological outcomes and in-hospital mortality rates of endovascular aortic repair patients
    Authors: L Altınay, EC Sungur, İ İnce
    Year: 2022
    Citations: 1

  • Title: Does sternal cable system prevent sternal complications after revision sternal surgery?
    Authors: L Altınay, EC Sungur, A Özen, A Tekin, SA Turan, G Yiğit, U Tütün
    Year: 2021
    Citations: 1

  • Title: Endovascular treatment of popliteal artery aneurysms: A report of three cases
    Authors: E Coşkun, L Altınay, A Tekin, U Tütün
    Year: 2020
    Citations: 1

  • Title: Endovascular repair of a dual abdominal aortic aneurysm in Behçet’s disease
    Authors: E Coşkun, L Altınay, A Tekin, U Tütün
    Year: 2019
    Citations: 1

  • Title: Periferik arter hastalığında asetilsalisilik asit ve klopidogrel cevapsızlığı
    Authors: E Coşkun, VY İmren
    Year: 2017
    Citations: 1

  • Title: Surgical revascularization of a rosary bead-like coronary artery aneurysm: Case report
    Authors: E Coşkun
    Year: 2017
    Citations: 1

Vipul Wayal | Immunology and Microbiology| Excellence in Research Award

Dr. Vipul Wayal | Immunology and Microbiology| Excellence in Research Award

Postdoctoral Researcher at Tunghai University, Taiwan

Dr. Vipul Rohidas Wayal is a dynamic postdoctoral researcher specializing in biotechnology, translational medicine, and pharmaceutical sciences. Currently affiliated with Tunghai University in Taiwan, he has demonstrated exceptional expertise in bioactive peptides, metabolic diseases, and immunomodulation. His research has led to several high-impact publications and internationally recognized patents, reflecting strong innovation and translational potential. With a solid academic foundation—holding a Ph.D. in Animal Science and Biotechnology and a Master’s in Pharmaceutics—Dr. Wayal brings interdisciplinary proficiency across advanced bioinformatics, molecular docking, and animal modeling. He has actively contributed to projects targeting MAFLD, T2DM, and atherosclerosis and participated in global scientific forums such as BIO Asia and the Taiwan Innotech Expo. Recognized with scholarships and innovation awards, he is also skilled in scientific writing, grant proposals, and technology transfer. Dr. Wayal’s research impact and forward-thinking approach position him as a promising candidate for honors recognizing excellence in scientific research and innovation.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Dr. Vipul Rohidas Wayal has a robust academic background, reflecting a consistent focus on biomedical research and pharmaceutical sciences. He earned his Ph.D. in Animal Science and Biotechnology from Tunghai University, Taiwan, where his thesis explored the ameliorative effects of bioactive oligopeptides on metabolic-associated fatty liver disease (MAFLD) in murine models. His doctoral work integrated molecular biology, pharmacology, and biotechnology. Prior to this, he completed a Master of Pharmacy (M.Pharm) in Pharmaceutics from Rajiv Gandhi University of Health Sciences, Bangalore, India. His master’s thesis focused on the development of silk protein-based topical sprays for wound healing. Dr. Wayal also holds a Bachelor of Pharmacy from Savitribai Phule Pune University, India, where he conducted research on herbal gel formulations for wound healing. Throughout his education, he has cultivated expertise in drug delivery, biotechnology, and disease modeling, laying a solid foundation for translational research and pharmaceutical innovation.

Professional Experience

Dr. Wayal brings diverse professional experience, combining academic research with industrial roles. He currently serves as a postdoctoral researcher at Tunghai University, Taiwan, where he is involved in projects focusing on novel fermented foods, immunomodulators, and bioactive peptides for metabolic disorders such as NAFLD and T2DM. His earlier academic experience includes extensive work in molecular biology techniques, animal experimentation, and peptide-based therapeutic research. Before transitioning fully into academia, he held several positions in the pharmaceutical industry in India, including Factory Manager at Equine Nutrients and R&D Production Manager at Fibroheal Woundcare Pvt. Ltd., where he was involved in the development and manufacturing of wound-care products. Additionally, he worked as a Manufacturing Officer at Fresenius Kabi, handling large-scale pharmaceutical production. These roles have equipped him with hands-on expertise in technology transfer, quality control, and product development, giving him a practical perspective that complements his research endeavors.

Research Interest

Dr. Vipul Wayal’s research interests lie at the intersection of biotechnology, pharmaceutical sciences, and translational medicine. He is particularly focused on the discovery and functional evaluation of bioactive peptides and proteins for the prevention and treatment of metabolic diseases such as MAFLD, type 2 diabetes, and atherosclerosis. His work integrates molecular docking, bioinformatics, in vivo modeling, and immunological assays to uncover therapeutic pathways and mechanisms, particularly involving Nrf2/HO-1, TLR4/NF-κB, and inflammasome signaling. Additionally, he is involved in the development of functional foods with cardiovascular and immunomodulatory benefits. His broad skill set includes protein purification, ELISA, flow cytometry, and various forms of chromatography and spectroscopy, which support his bench-to-bedside research approach. Dr. Wayal also emphasizes innovative drug delivery systems, especially in peptide-based therapeutics, and is passionate about bridging the gap between laboratory discoveries and clinical applications through patentable, scalable solutions.

Award and Honor

Dr. Vipul Wayal has received recognition for both his academic performance and innovative research contributions. He was awarded the Tunghai University International Student Scholarship consecutively for the academic years 2021–2022 and 2022–2023, acknowledging his academic excellence and research productivity during his doctoral studies. One of his most notable achievements includes receiving the Excellent Idea Certificate for his patented innovation on “Novel Small Molecule Peptides for Anti-MAFLD Activity,” which has been granted in Taiwan and Japan and filed in the United States. His participation in international expos and conferences, such as the Taiwan Innotech Expo and BIO Asia–Taiwan, further emphasizes his growing international profile. These honors reflect his commitment to advancing science through novel and applicable innovations. While his accolades are notable, they also signal his potential for future recognition as his research continues to expand and influence both academic and applied biomedical fields.

Conclusion

In conclusion, Dr. Vipul Rohidas Wayal exemplifies a rising biomedical scientist with an impressive combination of academic excellence, industrial experience, and innovative research. His work in bioactive peptides, metabolic disease therapeutics, and functional food development has resulted in impactful publications and internationally recognized patents. He possesses a wide range of technical skills, from molecular biology to in silico modeling, supported by a solid educational foundation and cross-disciplinary collaborations. With experience spanning academia and pharmaceutical industries, Dr. Wayal effectively bridges fundamental research and real-world applications. His contributions demonstrate both scientific rigor and translational value, making him a strong contender for recognition such as the BExcellence in Research Award. As he continues to lead and contribute to projects addressing global health challenges, his trajectory indicates not only a promising research career but also the capacity to impact public health through innovation and scientific excellence.

Publications Top Notes

  • Title: Novel bioactive peptides alleviate Western diet-induced MAFLD…
    Authors: V. Wayal, S.D. Wang, C.C. Hsieh
    Journal: International Immunopharmacology 148
    Year: 2025
    Citations: 8

  • Title: Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced MAFLD…
    Authors: V. Wayal, C.C. Hsieh
    Journal: Biomedicine & Pharmacotherapy 168
    Year: 2023
    Citations: 7

  • Title: ASSESSMENT OF WOUND HEALING ACTIVITY OF POTENT HERBAL EXTRACTS GEL IN ALBINO WISTAR RAT
    Authors: V. Wayal, T.N.V.
    Journal: Asian Journal of Pharmaceutical and Clinical Research 15(08)
    Year: 2022
    Citations: 3

  • Title: Design, Development and Evaluation of Silk Based Film Forming Spray for Wound Healing
    Authors: V. Wayal, K. Nagasree, B.A. Vishwanath
    Journal: Journal of Drug Delivery & Therapeutics 11
    Year: 2021
    Citations: 3

  • Title: Chicken meat hydrolysate improves acetaminophen-induced liver injury…
    Authors: V. Wayal, Z.E. Tsai, Y.H. Lin, Y.H. Lai, S.D. Wang, C.C. Hsieh
    Journal: Journal of Agriculture and Food Research 21
    Year: 2025
    Citations: 1

  • Title: Immunomodulatory effects of type II arabinogalactans from Anoectochilus formosanus…
    Authors: Y.L. Huang, W.C. Lin, V. Wayal, C.C. Hsieh
    Journal: Carbohydrate Polymer Technologies and Applications
    Year: 2025

  • Title: Goat Whey Protein Hydrolysate Mitigates High-Fructose Corn Syrup-Induced Hepatic Steatosis…
    Authors: C.H. Shao, V. Wayal, C.C. Hsieh
    Journal: Preprints
    Year: 2025

  • Title: Type II Arabinogalactan from Anoectochilus Formosanus Dampens Allergic Airway Hyperresponsiveness…
    Authors: Y.L. Huang, V. Wayal, W.C. Lin, C.C. Hsieh
    Platform: SSRN Preprint
    Year: 2025